Saireito in Catheter Ablation for Atrial Fibrillatio

Phase 4

• Conditions: Atrial fibrillation; D001281

• Registration Number: JPRN-jRCTs051200037
• Lead Sponsor: Shizuta Satoshi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-07-30
• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

First time ablation procedure for symptomatic atrial fibrillation
Patients who can be followed for 1-year after procedure
Patients from who we get written informed consent

Exclusion Criteria

Severe complications of ablation procedure
Patients who received ablation procedure or MAZE procedure for for atrial fibrillation before enrollment
Patients who already take Saireito
Chronic kidney disease (eGFR<30 or hemodialysis)
Chronic liver failure
Patients who can not take Saireito

Study & Design

• Study Type: Interventional
• Study Design: Not specified